5 News results found for "Antibody".

Meetings - 28 Jun 2022

10th Antibody Industrial Symposium AIS2022

Raphaëlle Gillet and Nicolas Bouquin will be speaking on June 28, 2022, at the 10th edition of the AIS, the major symposium in the field of therapeutic antibodies. More information

By Lazarina Choisnel et Cécile Puech
Meetings - 22 Jun 2021

AIS 2021 – Protecting epitope versus paratope: Case study from Amgen PCSK9

Raphaëlle Gillet and Nicolas Bouquin will discuss the latest decisions regarding antibody patents and in particular the Amgen PCSK9 case at AIS 2021, on June 23rd 2021 at 2PM. Check…

By Lazarina Choisnel et Cécile Puech
Meetings - 23 Nov 2020

Antibody Industrial Symposium 2020

Contribution on the Challenges & Perspectives of Intellectual Property in Immunotherapy by Raphaëlle Gillet, French and European Patent Attorney and Sara Haines, US Patent Agent to AIS congress 2020. AIS…

By Lazarina Choisnel et Cécile Puech
Meetings - 24 Sep 2019

Bioproduction of Immunotherapies

Contribution by Cécile Puech on “Patent battles over antibody production (Upstream Processing) and territory constraints.” and participation of Gabrielle Faure-André at the 4th edition Bioproduction of Immunotherapies

By Lazarina Choisnel et Cécile Puech
Releases - 24 May 2019

Mabdesign and Regimbeau announce strategic partnership

MABDESIGN, the organization for the French therapeutic antibody and immunotherapy industrial sector, with more than 140 members, has signed a partnership agreement with REGIMBEAU, an intellectual property law firm. This…

By Lazarina Choisnel et Cécile Puech